.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Deloitte
Express Scripts
UBS
McKesson
Harvard Business School
Merck
Argus Health
Healthtrust
Fuji

Generated: December 18, 2017

DrugPatentWatch Database Preview

OXYMORPHONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Oxymorphone Hydrochloride patents expire, and when can generic versions of Oxymorphone Hydrochloride launch?

Oxymorphone Hydrochloride is a drug marketed by Actavis Elizabeth, Impax Labs, Mallinckrodt Inc, Par Pharm, Sun Pharm Inds Ltd, West-ward Pharms Int, Aurolife Pharma Llc, Avanthi Inc, Epic Pharma Llc, and Teva. and is included in twelve NDAs.

The generic ingredient in OXYMORPHONE HYDROCHLORIDE is oxymorphone hydrochloride. There are nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the oxymorphone hydrochloride profile page.
Drug patent expirations by year for OXYMORPHONE HYDROCHLORIDE

Pharmacology for OXYMORPHONE HYDROCHLORIDE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for OXYMORPHONE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200822-007Jul 15, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL203506-004Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt IncOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET;ORAL202321-001Apr 25, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Avanthi IncOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET;ORAL203601-001Jan 30, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt IncOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET;ORAL202321-002Apr 25, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Par PharmOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200792-007Oct 24, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL203506-005Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL203506-001Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis ElizabethOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL079046-003Jul 11, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt IncOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL202946-004Jun 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
US Department of Justice
Boehringer Ingelheim
Fuji
Merck
Johnson and Johnson
Teva
Medtronic
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot